This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Epitech Group S.p.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Claudia Cristiano and Her Patent on Autism Spectrum Disorder Treatment.
Introduction
Claudia Cristiano is an inventor associated with Milan, Italy. Her patent work concerns a proposed combination of N-palmitoylethanolamide (PEA) and docosahexaenoic acid (DHA) for treating autism spectrum disorder and other depressive syndromes.
Latest Patents
Cristiano is listed as an inventor on 1 patent: “N-palmitoylethanolamide and docosahexaenoic acid for use in the treatment of autism spectrum disorder and other depressive syndromes.” The patent describes using PEA in combination with DHA to treat these conditions, particularly diseases associated with decreased endogenous levels of allopregnanolone.
Career Highlights
The provided information associates Cristiano with Epitech Group S.p.A. and the University of Bari Aldo Moro. These affiliations connect her work with both a company and a university.
Collaborations
Cristiano’s named collaborators include Chiara Gomiero and Francesco Della Valle.
Conclusion
Claudia Cristiano’s listed patent focuses on a PEA-and-DHA combination for autism spectrum disorder and other depressive syndromes, reflecting her work in therapeutic innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile